Search research articles
Contact Us
Filters
Showing results (81-90 of 145) with videos related to
Page
of 15
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors
Yukiko Komeno, Yoshinobu Kanda, Tamae Hamaki, et al.
Free Radical Biology & Medicine
|
April 24, 2007
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis
Shohei Watanabe, Seiichi Nagano, James Duce, et al.
International Journal of Hematology
|
January 6, 2026
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype
Hiroki Yokoyama, Masamitsu Yanada, Shohei Mizuno, et al.
International Journal of Hematology
|
April 6, 2011
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
Minako Iida, Takahiro Fukuda, Kazuhiro Ikegame, et al.
Transfusion
|
November 1, 2025
Evaluation of peripheral blood stem cell collection in the Japan Marrow Donor Program (JMDP)
Rie Yamazaki, Kimikazu Yakushijin, Satoshi Yoshihara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 30, 2015
Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan
Kazuhiro Ikegame, Takashi Yoshida, Satoshi Yoshihara, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2004
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone
Hiroko Nakajima, Kotomi Kawasaki, Yoshihiro Oka, et al.
Cytotherapy
|
October 25, 2024
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation
Masaharu Tamaki, Shunto Kawamura, Kosuke Takano, et al.
Transplantation and Cellular Therapy
|
March 17, 2025
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan
Akihito Shinohara, Michiho Shindo, Satoshi Yamasaki, et al.
Blood Neoplasia
|
October 27, 2025
Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemia
Tomoyasu Jo, Tadakazu Kondo, Shohei Mizuno, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 145) with videos related to
Sort By:
Page
of 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 2006
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donors
Yukiko Komeno, Yoshinobu Kanda, Tamae Hamaki, et al.
Free Radical Biology & Medicine
|
April 24, 2007
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis
Shohei Watanabe, Seiichi Nagano, James Duce, et al.
International Journal of Hematology
|
January 6, 2026
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotype
Hiroki Yokoyama, Masamitsu Yanada, Shohei Mizuno, et al.
International Journal of Hematology
|
April 6, 2011
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
Minako Iida, Takahiro Fukuda, Kazuhiro Ikegame, et al.
Transfusion
|
November 1, 2025
Evaluation of peripheral blood stem cell collection in the Japan Marrow Donor Program (JMDP)
Rie Yamazaki, Kimikazu Yakushijin, Satoshi Yoshihara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 30, 2015
Unmanipulated Haploidentical Reduced-Intensity Stem Cell Transplantation Using Fludarabine, Busulfan, Low-Dose Antithymocyte Globulin, and Steroids for Patients in Non-Complete Remission or at High Risk of Relapse: A Prospective Multicenter Phase I/II Study in Japan
Kazuhiro Ikegame, Takashi Yoshida, Satoshi Yoshihara, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2004
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone
Hiroko Nakajima, Kotomi Kawasaki, Yoshihiro Oka, et al.
Cytotherapy
|
October 25, 2024
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation
Masaharu Tamaki, Shunto Kawamura, Kosuke Takano, et al.
Transplantation and Cellular Therapy
|
March 17, 2025
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan
Akihito Shinohara, Michiho Shindo, Satoshi Yamasaki, et al.
Blood Neoplasia
|
October 27, 2025
Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemia
Tomoyasu Jo, Tadakazu Kondo, Shohei Mizuno, et al.
Page
of 15